PH009-1

· Suzhou Puhe Pharmaceutical Technology Co., LTD

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PH009-1, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

See pricing